Medroxyprogesterone and Ranibizumab ophthalmic
Determining the interaction of Medroxyprogesterone and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: MedroxyPROGESTERone
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Medroxyprogesterone-Ranitidine
- Medroxyprogesterone-Ranitidine Capsule
- Medroxyprogesterone-Ranitidine Hydrochloride
- Medroxyprogesterone-Ranitidine Injection
- Medroxyprogesterone-Ranitidine Suspension
- Medroxyprogesterone-Ranitidine Syrup
- Ranibizumab ophthalmic-Medroxyprogesterone Acetate
- Ranibizumab ophthalmic-Medroxyprogesterone injection
- Ranibizumab ophthalmic-Medroxyprogesterone Injection (400 mg/mL)
- Ranibizumab ophthalmic-Medroxyprogesterone Injection (Intramuscular)
- Ranibizumab ophthalmic-Medroxyprogesterone Injection (Subcutaneous)
- Ranibizumab ophthalmic-Medroxyprogesterone Injection ER